David Christensen
Directeur/Membre du Conseil chez Upstream Medical Technologies Ltd.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Chris Pemberton | M | - |
Upstream Medical Technologies Ltd.
 Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand. | 9 ans |
| Gary Pace | M | 76 |
Upstream Medical Technologies Ltd.
Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand. | - |
| Judith Swain | M | 75 |
Upstream Medical Technologies Ltd.
Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand. | - |
| Roland Toder | M | - |
Upstream Medical Technologies Ltd.
Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand. | - |
| Colin Ernest Dawson | M | - |
Upstream Medical Technologies Ltd.
Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand. | 9 ans |
| Kieran Craig Jina | M | - |
Upstream Medical Technologies Ltd.
Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand. | 5 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Nouvelle-Zélande | 6 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- David Christensen
- Réseau Personnel
